M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Everest Medicines Announces the Implementation of NEFECON NRDL Pricing in China
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
SHANGHAI, China - - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search